Testicular sperm extraction and intracytoplasmic sperm injection outcome in cancer survivors with no available cryopreserved sperm.
Paolo Emanuele Levi-SettiLuciano NegriAnnamaria BaggianiEmanuela MorenghiElena AlbaniCarola Maria Conca DioguardiCristina SpecchiaPasquale PatrizioPublished in: Journal of assisted reproduction and genetics (2020)
The rate of successful TESE and the ICSI outcome in cancer survivors with NOA and RE/FOE is the same as non-cancer azoospermic patients. Female partner age (older than 40 years) was associated with a significant reduction in live birth rates after TESE-ICSI procedures.
Keyphrases
- end stage renal disease
- young adults
- ejection fraction
- newly diagnosed
- childhood cancer
- chronic kidney disease
- pregnancy outcomes
- prognostic factors
- papillary thyroid
- peritoneal dialysis
- physical activity
- squamous cell carcinoma
- mesenchymal stem cells
- bone marrow
- cord blood
- lymph node metastasis
- antiretroviral therapy